Persistent URL of this record https://hdl.handle.net/1887/100758
In Collections
This item can be found in the following collections:
![WHAT IS THE VALUE OF BIOMARKERS FOR DRUG DEVELOPMENT IN OSTEOARTHRITIS?](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
WHAT IS THE VALUE OF BIOMARKERS FOR DRUG DEVELOPMENT IN OSTEOARTHRITIS?
- All authors
- Lotz, M.; Martel-Pelletier, J.; Christiansen, C.; Berenbaum, F.; Brandi, M.L.; Bruyere, O.; Chapurlat, R.; Colette, J.; Cooper, C.; Heinegard, D.; Kanis, J.A.; Kraus, V.; Laslop, A.; Lems, W.; Lohmander, S.; Meulenbelt, I.; Pelletier, J.P.; Raynauld, J.P.; Reiter, S.; Rizzoli, R.; Sandel, L.; Spector, T.; Spil, W.E. van; Reginster, J.Y.
- Date
- 2013-04-30
- Journal
- Osteoporosis International
- Volume
- 24
- Pages
- S77 - S78